Latest Features & Opinion

Re-Examining Infectious Causes of Alzheimer's Disease

Theodore Henderson, MD, PhD, suggests that perhaps it's time to check our bias at the door.

Treating Epilepsy and Comorbid Intellectual Disability

With a lack of official treatment guidelines, clinicians should remember to treat the patient, not just the condition.

Migraine Research Update

Huma U. Sheikh, MD, provides highlights of recent clinical research in headache.

AAN 2016 Annual Meeting Coverage

Live coverage from the 2016 American Academy of Neurology Annual Meeting in Vancouver, Canada.

Psychiatric Comorbidities in Pediatric Chronic Headache

Children and teens with chronic headache pain should be screened for anxiety and depression.

Depression: A Lasting Impact in MS

Physical comorbidities are mediated by depression in MS.

Can We Make Football Safer?

Changing the stigma around and frequency of injury in football requires a collaborative, educational effort involving all stakeholders.

Case Study: Treatment of Refractory Seizures ...

Dr Mary Zupanc of CHOC Children's recounts a challenging case of refractory seizures in a child with a history of arteriovenous malformation and intracranial hemorrhage.
More Choices for the Secondary Prevention of Stroke

More Choices for the Secondary Prevention of Stroke

Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.

International Stroke Conference 2016

Hot Topics in Stroke With Advisory Board Member Albert Favate, MD

Hot Topics in Stroke With Advisory Board Member Albert Favate, MD

Dr Albert Favate addresses some of the hottest topics concerning stroke care and patient management.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorders

High Folate, B12 Levels in Pregnancy May Raise Autism Risk

Researchers will now have to explore the optimal dose for the supplements.

Weighing the Benefits of Risperidone in Autism

Treatment with risperidone over a 6 month period was associated with an average weight gain of 5.4±3.4kg.

Remote Eye Tracking Could Effectively Measure Autism Risk

Objective measures of autism symptom severity are necessary to accurately diagnose autism and measure the effectiveness of treatment interventions.

Latest in Neuromuscular Disorders

FDA Delays Decision on Duchenne Muscular Dystrophy Drug

This is the second extension requested by the FDA.

FDA Panel Votes Down Duchenne Muscular Dystrophy Drug Eteplirsen

The panel took a similar stance in the fall when it did not recommend Biomarin's drisapersen for the treatment of DMD.

Stem Cell Transplant May Promote Remission in Myasthenia Gravis

Treatment has been linked to durable, symptom-free, treatment-free remission in several cases of MG.

Sign Up for Free e-newsletters